Sustainability goal indicators

in page functions

To improve sustainability of national immunisation programmes

Countries on track to successful transition

What we measure: the percentage of countries in the accelerated transition phase that are on track to transition successfully. A country is on track if:

  • at least 75% of predefined transition activities (such as having a functional national regulatory agency) have been completed on time;
  • DTP3 coverage has increased over the last three years (if a country has already achieved at least 90% DTP3 coverage, this level should have been sustained for three years); and
  • it is meeting its co-financing obligations and did not default on payments in the previous year.


What we measure: the percentage of countries that fulfil their co-financing commitments by the end of the year, or who pay their arrears in full within 12 months.

Country investments in routine immunisation

What we measure: the percentage of countries that have increased their investment in routine immunisation per child, relative to 2015.

This indicator takes into account every vaccine in a country’s national programme, not just those supported by Gavi. It also includes expenditure on related products, such as injection supplies.

Institutional capacity

What we measure: the average score of Gavi-supported countries measured against our criteria for national decision-making, programme management and monitoring.

Through this indicator, we assess the performance and effectiveness of bodies that manage immunisation, including the Expanded Programme on Immunization, interagency coordinating mechanisms and national immunisation technical advisory groups.


US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016

More facts...

close icon

modal window here